ArticleTheranostics2026

Autocrine activity of engineered IL-33 mRNA enhances adoptive T-cell therapy for peritoneal carcinomatosis and synergizes with IL-12 mRNA.

Leire Arrizabalaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.